tiprankstipranks
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF

RepliCel Life Sciences (REPCF) Technical Analysis

22 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
RepliCel Life Sciences Inc’s (REPCF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting RepliCel Life Sciences Inc is a Sell.
RepliCel Life Sciences Inc’s (REPCF) 20-Day exponential moving average is 0.04, while RepliCel Life Sciences Inc’s (REPCF) share price is <$0.1, making it a Sell.
RepliCel Life Sciences Inc’s (REPCF) 50-Day exponential moving average is 0.04, while RepliCel Life Sciences Inc’s (REPCF) share price is <$0.1, making it a Sell.

RepliCel Life Sciences (REPCF) Pivot Points

Jul 23, 2024, 07:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Fibonacci
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RepliCel Life Sciences (REPCF) Moving Averages

Jul 23, 2024, 07:16 PM
Period
Simple
Exponential
MA5
0.04Buy
0.04Sell
MA10
0.04Sell
0.04Sell
MA20
0.04Buy
0.04Sell
MA50
0.04Sell
0.04Sell
MA100
0.04Sell
0.04Sell
MA200
0.05Sell
0.06Sell
RepliCel Life Sciences Inc’s (REPCF) 10-Day exponential moving average is 0.04, while RepliCel Life Sciences Inc’s (REPCF) share price is <$0.1, making it a Sell.
RepliCel Life Sciences Inc’s (REPCF) 100-Day exponential moving average is 0.04, while RepliCel Life Sciences Inc’s (REPCF) share price is <$0.1, making it a Sell.
RepliCel Life Sciences Inc’s (REPCF) stock price is <$0.1 and RepliCel Life Sciences Inc’s (REPCF) 50-day simple moving average is 0.04, creating a Sell signal.
RepliCel Life Sciences Inc’s (REPCF) stock price is <$0.1 and RepliCel Life Sciences Inc’s (REPCF) 100-day simple moving average is 0.04, creating a Sell signal.
RepliCel Life Sciences Inc’s (REPCF) stock price is <$0.1 and RepliCel Life Sciences Inc’s (REPCF) 200-day simple moving average is 0.05, creating a Sell signal.

RepliCel Life Sciences (REPCF) Technical Indicators

Jul 23, 2024, 07:16 PM
Name
Value
Implied Action
RSI (14)
44.29
Neutral
STOCH (9,6)
>-0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
51.07
Sell
CCI (14)
0.00
-
ATR (14)
<0.01
-
Ultimate Oscillator
>-0.01
Sell
ROC
0.00
-
Bull/Bear Power (13)
<0.01
Buy
RepliCel Life Sciences Inc’s (REPCF) Relative Strength Index (RSI) is 44.29, creating a Neutral signal.
RepliCel Life Sciences Inc’s (REPCF) Trend Strength Indicator (ADX) is 51.07, creating a Sell signal.

FAQ

Is REPCF a Buy, Hold, or Sell?
Based on REPCF’s technical indicators, REPCF is a Sell.
    What is REPCF’s RSI (14)?
    REPCF’s RSI (14) is 44.29, which suggests REPCF is a Neutral.
      What is REPCF’s MACD?
      REPCF’s MACD is >-0.01, which suggests REPCF is a Sell.
        What is REPCF’s 5-day moving average?
        REPCF’s 5-day moving average is 0.04, which suggests REPCF is a Buy.
          What is REPCF’s 20-day moving average?
          REPCF 20-day moving average is 0.04, which suggests REPCF is a Buy.
            What is REPCF’s 50-day moving average?
            REPCF’s 50-day moving average is 0.04, which suggests REPCF is a Sell.
              What is REPCF’s 200-day moving average?
              REPCF’s 200-day moving average is 0.05, which suggests REPCF is a Sell.
                What is REPCF’s Williams % R (14)?
                Currently, no data Available
                What is REPCF’s CCI (14)?
                Currently, no data Available
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis